Melatonin agonists for use in the treatment of benign prostatic

Details Melatonin agonists for use in the treatment of benign prostatic Melatonin agonists for use in the treatment of benign prostatic

1996-06-11

1998-06-23

Henley, III, Raymond

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

A61K 31405

Patent

active

057706107

ABSTRACT:
The present invention provides a method for the treatment of benign prostatic hyperplasia using various melatonin agonists.

REFERENCES:
patent: 4600723 (1986-07-01), Short et al.
patent: 4614807 (1986-09-01), Flaugh
patent: 4997845 (1991-03-01), Flaugh
patent: 5196435 (1993-03-01), Clemens et al.
patent: 5242941 (1993-09-01), Lewy et al.
Chem. Pharm Bull., 40(4), 1066-1068 (1992).
Life Sciences, vol. 10, Part I, pp. 259-269 (1971).
Journal of Endocrinology (1990) 126, 431-435.
J. Endocr. (1988) 116, 43-53.
Craig et al. "Modern Pharmacology", published by Little, Brown and Company (Boston), p. 16, 1982.

Affiliated with

Also associated with

Rating

Melatonin agonists for use in the treatment of benign prostatic does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Melatonin agonists for use in the treatment of benign prostatic , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Melatonin agonists for use in the treatment of benign prostatic will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1395063